Admissions:
Delistings:
Merit Group (MRIT.L) left AIM.
Potential** Initial Public Offerings:
Upcoming Market Movers:
6 February: GlobalData (DATA.L) has announced an intention to move to the Main Market from AIM. An update on the timing and process to seek Admission will be provided in due course.
6 February: Creightons (CRL.L) has announced an intention to move to AIM from the Main Market. It is expected that the last day of dealings in the Ordinary Shares on the Main Market will be 28 March 2025. Dealing in the Ordinary Shares is expected to commence on AIM, at 8.00 a.m. on 31 March.
BATM Advanced Communications LD 17.25p £75.30m (BVC.L)
The provider of real-time technologies for networking solutions and medical laboratory systems updated on trading for YE December 2024 and its strategy. The broad strategy is to focus on its core strengths of cyber security, networks and diagnostics, and to dispose of non-core assets. It continues to explore potential
M&A opportunities and to divest its non-core businesses. Its first disposal is Progenetics, a non-core asset, for approximately $2m in cash for its 51% shareholding. It continues to seek to sell its eco-med activities, but if a sale does not occur in 2025, it will be closed. BTAM’s revenue for 2024 is expected to be at least $117m (2023: $116.7m), which was achieved against a backdrop of challenging macroeconomic and geopolitical conditions. The adjusted EBITDA for continuing operations was lower at $8m (2023: $9.9m) while the cash position is $31.6m (2023:$32.6m). A partnership is set to deliver cutting-edge encryption platforms to commercial markets, which has long been a key objective and BTAM is confident of strong positive momentum.
Gelion 13.25p £19.67m (GELN.L)
The Anglo-Australian battery innovator yesterday announced £175k of grant funding from the Department for Business and Trade. It is for Phase 2 of the programme to accelerate the commercialisation of its Lithium-Ion recycling technology. Phase 1 was to engage prospective customers and Phase 2 is focusing on the Technology Validation. This development could potentially support a feasibility study for a larger scale pilot plant. The growing volume of battery waste presents an economic opportunity projected to be worth $30bn - $40bn globally by 2030.
Kanabo Group 0.775p £4.9m (KNB.L)
The provider of digital health services and specialised medicines (including medicinal cannabis) yesterday gave a trading and strategic update for its YE December 2024. Its revenue grew by 44% to £1.3m with an Operating EBITDA loss down from £2.2m to £1.9m. The core focus is on closing strategic projects and refining operational efficiency. Kanabo plans to diversify the TreatIt Clinic's extending its chronic pain management and mental health indications, offering patients access to secondary care. The Company continues to evaluate its capital needs and its divisional funding requirements.
LPA Group 55p £7.27m (LPA.L)
The innovation-led engineering specialist in electronic and electro-mechanical components and systems has won a £1.72m contract. It is from a major UK-based train builder to supply rail inter-car jumpers for the replacement programme on the Electrostar fleet with deliveries starting immediately. The contract demonstrates the rail aftercare market continues to be one of its key sectors.
Metals Exploration 5.4p £138.9m (MTL.L)
The gold production, exploration, and development Company with assets in the Philippines and Nicaragua has agreed to purchase a gold ore processing and concentrating plant. The $9.7m price to be paid from existing resources includes it being for crushers, conveyors, and a grinding ball mill. It will be transported to its La India project area in Nicaragua, saving the project significant time and costs andis expected to be in production by Q4 2026.
Netcall 115p £189m (NET.L)
The provider of intelligent automation and customer engagement software reports its Interims to December 2024. There is a 22% increase in revenue to £23m, with particularly strong growth in its cloud services. The EBITDA improved 18% to £5.6m, while the PBT is 5% lower at £3.7m. Net cash is £20.9m ,down from £28.1m. Organic growth was helped by the synergistic acquisitions of Govtech and Parble, which enhanced new customer and cross-sell opportunities. The predictable, recurring revenue, increased 23% to £71.1m, and there is positive sales momentum in H2.
Northcoders 122.5 £9.09m (CODE.L)
Leader in technology training in the UK announces that it has secured a new finance agreement to support the Company’s next stage of growth with NatWest for a £1.5m facility. This includes the £0.4m refinance of the existing 11% loan with Creative England, secured over three years, at a significantly improved fixed rate of 3.5% above base and £1.0m over four years, at a fixed rate of 2.5% above base. The additional funds will be available to support the next stage of Northcoders growth as the Company continues to diversify its revenue streams. The loan also offers the option to increase the facility each year, subject to IP valuation monitoring. Northcoders also announces it is launching a brand new B2C Training Bootcamp course focusing on AI and Machine Learning covering the principles of Data Engineering, Machine Learning, Cloud Technologies and the Engineering at the heart of AI language models.
Prior1ty Intelligence Group 4p £5.32m (PR1.L)
Th AI Company transforming professional growth services for SMEs announces a new 50:50 partnership with Halfspace Group, a UK sports data and marketing company. A new product, Capitano Ai, is to be launched to help sports and media organisations to immediately unlock meaningful insights from their extensive data repositories via simple conversational queries, marking a significant advancement in sports data intelligence. It is expected to offer a significant level of analytics at a competitive price point and reduces the need for fragmented data points. The Company says the addressable market is set to grow.
Rosslyn Data Technologies 4.5p £3.3m (RDT.L)
The provider of cloud-based spend intelligence platform updates on trading for the YE April 2025. There was a
strong start to H2 due mainly to securing a major new household name as a client. The solution it provided has been well-received, and the client intends to roll it out to further departments, this is however expected to be in the next financial year. As a result, RDT now expects to report revenue for FY April 2025 of £3.3m, representing year-on-year growth of 14% and an improved adj. EBITDA to a £1.7m loss from a £2.5m loss from April 2024. The YE net cash is expected to be £1.7m and management reports being on track to deliver strong growth and expects to become cash generative by the end of FY 2026 .
Tekmar Group 6.25p £8.6m (TGP.L)
Tekmar's technology and engineering services business providing engineering led solutions for energy transition customers yesterday reported finals for the year to September. It reported an adjusted EBITDA of £1.7m on revenue of £33m compared to last year’s £0.6m on revenue of £36m. The operating loss reduced from £7.9m to £3.8m in the year as a result of the profit improvement plan. There is a refreshed three-year growth strategy under new CEO, Richard Turner, who was appointed in September 2024. The plan focuses on achieving greater scale through accelerated profitable organic growth and complementary M&A. Net debt is £1.6m, but this excludes the SCF Capital Partners £18m CLN facility which remains undrawn and is available to drive growth through acquisitions.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
